Clear overexpression is seen in tumors that have metabolically active oxidative environments, such as hepatocellular carcinoma, renal cell carcinoma or non-small cell lung adenocarcinoma, while in some malignancies, such as multiple myeloma, fewer than half cancerous cells were showing MTH1 overexpression. Here, NUDT1 is linked to hereditary clear cell renal cell carcinoma.